Stock Information
Roivant Sciences Ltd (ROIV)
Ticker Symbol: ROIV
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $20,141.44 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -1.1684
Revenue (TTM): $0.02 M
Dividend Yield: N/A%
ROE: -18.32%
Latest News
-
Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates
Fri, May 15, 2026 11:30 PM
-
ROIVANT SCIENCES LTD (NASDAQ:ROIV) Flashes Strong Breakout Setup with Near-Perfect Technical and Setup Quality Ratings
Thu, May 14, 2026 12:40 PM
-
Invivyd, Inc. (IVVD) Reports Q1 Loss, Lags Revenue Estimates
Thu, May 14, 2026 12:15 PM
-
Roivant Sciences Ltd. (ROIV) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Wed, May 13, 2026 4:50 PM
-
Transcript : Roivant Sciences Ltd. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 10
Wed, May 13, 2026 4:50 PM
-
Fate Therapeutics (FATE) Reports Q1 Loss, Misses Revenue Estimates
Wed, May 13, 2026 1:40 PM
-
Metagenomi Therapeutics (MGX) Reports Q1 Loss, Misses Revenue Estimates
Tue, May 12, 2026 12:05 AM
-
Immunovant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026, and Provide Business Update on Wednesday, May 20, 2026
Mon, May 11, 2026 8:05 PM
-
Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provide Business Update on Wednesday, May 20, 2026
Mon, May 11, 2026 8:05 PM
Key Financials
Financial data not available
